Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025)

Autolus Therapeutics (AUTL) has 8 years of Other Operating Expenses data on file, last reported at $25.3 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $25.3 million; the trailing twelve-month figure through Dec 2025 stood at $25.3 million (up 11456.05% YoY), and the FY2025 full-year result was $96.4 million, up 43314.8% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $25.3 million, up from -$3000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $25.3 million in Q4 2025 and bottomed at -$3.8 million in Q1 2023.
• The 5-year median for Other Operating Expenses is -$123000.0 (2023), against an average of $2.5 million.
• Peak annual rise in Other Operating Expenses reached 12775.0% in 2022, while the deepest fall reached 12775.0% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at -$4000.0 in 2021, then slumped by 12775.0% to -$515000.0 in 2022, then jumped by 95.53% to -$23000.0 in 2023, then tumbled by 869.57% to -$223000.0 in 2024, then jumped by 11457.4% to $25.3 million in 2025.
• The last three Other Operating Expenses figures came in at $25.3 million (Q4 2025), -$3000.0 (Q1 2025), and -$223000.0 (Q3 2024), per Business Quant data.

Peer Comparison